Hematopoietic Stem Cell Transplantation
"Hematopoietic Stem Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms.
Descriptor ID |
D018380
|
MeSH Number(s) |
E02.095.147.500.500.500 E04.936.225.687.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hematopoietic Stem Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Hematopoietic Stem Cell Transplantation".
This graph shows the total number of publications written about "Hematopoietic Stem Cell Transplantation" by people in this website by year, and whether "Hematopoietic Stem Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 2 | 2 | 4 |
1996 | 1 | 1 | 2 |
1997 | 3 | 0 | 3 |
1998 | 2 | 1 | 3 |
1999 | 2 | 2 | 4 |
2000 | 2 | 1 | 3 |
2001 | 1 | 1 | 2 |
2002 | 1 | 1 | 2 |
2003 | 1 | 0 | 1 |
2004 | 0 | 2 | 2 |
2005 | 1 | 0 | 1 |
2006 | 8 | 1 | 9 |
2007 | 1 | 4 | 5 |
2008 | 1 | 0 | 1 |
2009 | 2 | 2 | 4 |
2010 | 6 | 4 | 10 |
2011 | 5 | 2 | 7 |
2012 | 4 | 2 | 6 |
2013 | 2 | 2 | 4 |
2014 | 6 | 2 | 8 |
2015 | 5 | 1 | 6 |
2016 | 5 | 2 | 7 |
2017 | 5 | 1 | 6 |
2018 | 10 | 3 | 13 |
2019 | 4 | 1 | 5 |
2020 | 1 | 3 | 4 |
2021 | 7 | 2 | 9 |
2022 | 10 | 0 | 10 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hematopoietic Stem Cell Transplantation" by people in Profiles.
-
The Absence of IL-12R?2 Expression on Recipient Nonhematopoietic Cells Diminishes Acute Graft-versus-Host Disease in the Gastrointestinal Tract. J Immunol. 2023 02 15; 210(4):486-495.
-
Maintaining osteoclastogenesis following allogeneic hematopoietic stem cell transplantation for osteopetrosis: evidence from in vitro testing. Haematologica. 2022 11 01; 107(11):2760-2764.
-
The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease. J Clin Invest. 2022 11 01; 132(21).
-
S1P/S1PR1 signaling differentially regulates the allogeneic response of CD4 and CD8 T cells by modulating mitochondrial fission. Cell Mol Immunol. 2022 Nov; 19(11):1235-1250.
-
Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation. Front Immunol. 2022; 13:904823.
-
Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant. J Oncol Pharm Pract. 2022 Oct; 28(7):1613-1616.
-
Late pulmonary complications related to cancer treatment in children. Pediatr Radiol. 2022 09; 52(10):2029-2037.
-
MicroRNA-31 regulates T-cell metabolism via HIF1a and promotes chronic GVHD pathogenesis in mice. Blood Adv. 2022 05 24; 6(10):3036-3052.
-
Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathway. Leukemia. 2022 07; 36(7):1907-1915.
-
Safety and Efficacy of Mesenchymal Stromal Cells and Other Cellular Therapeutics in Rheumatic Diseases in 2022: A Review of What We Know So Far. Arthritis Rheumatol. 2022 05; 74(5):752-765.